Literature DB >> 15172699

Haploinsufficiency for tumour suppressor genes: when you don't need to go all the way.

Manuela Santarosa1, Alan Ashworth.   

Abstract

Classical tumour suppressor genes are thought to require mutation or loss of both alleles to facilitate tumour progression. However, it has become clear over the last few years that for some genes, haploinsufficiency, which is loss of only one allele, may contribute to carcinogenesis. These effects can either be directly attributable to the reduction in gene dosage or may act in concert with other oncogenic or haploinsufficient events. Here we describe the genes that undergo this phenomenon and discuss possible mechanisms that allow haploinsufficiency to display a phenotype and facilitate the pathogenesis of cancer.

Entities:  

Mesh:

Year:  2004        PMID: 15172699     DOI: 10.1016/j.bbcan.2004.01.001

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  66 in total

1.  High-resolution genomic profiling of chromosomal aberrations using Infinium whole-genome genotyping.

Authors:  Daniel A Peiffer; Jennie M Le; Frank J Steemers; Weihua Chang; Tony Jenniges; Francisco Garcia; Kirt Haden; Jiangzhen Li; Chad A Shaw; John Belmont; Sau Wai Cheung; Richard M Shen; David L Barker; Kevin L Gunderson
Journal:  Genome Res       Date:  2006-08-09       Impact factor: 9.043

2.  A Drosophila model of multiple endocrine neoplasia type 2.

Authors:  Renee D Read; Paul J Goodfellow; Elaine R Mardis; Nancy Novak; Jon R Armstrong; Ross L Cagan
Journal:  Genetics       Date:  2005-06-18       Impact factor: 4.562

3.  Molecular and cellular pathways associated with chromosome 1p deletions during colon carcinogenesis.

Authors:  Claire M Payne; Cheray Crowley-Skillicorn; Carol Bernstein; Hana Holubec; Harris Bernstein
Journal:  Clin Exp Gastroenterol       Date:  2011-05-03

4.  DEAR1 is a chromosome 1p35 tumor suppressor and master regulator of TGF-β-driven epithelial-mesenchymal transition.

Authors:  Nanyue Chen; Seetharaman Balasenthil; Jacquelyn Reuther; Aileen Frayna; Ying Wang; Dawn S Chandler; Lynne V Abruzzo; Asif Rashid; Jaime Rodriguez; Guillermina Lozano; Yu Cao; Erica Lokken; Jinyun Chen; Marsha L Frazier; Aysegul A Sahin; Ignacio I Wistuba; Subrata Sen; Steven T Lott; Ann McNeill Killary
Journal:  Cancer Discov       Date:  2013-07-09       Impact factor: 39.397

5.  Functional deficiency of DNA repair gene EXO5 results in androgen-induced genomic instability and prostate tumorigenesis.

Authors:  Shafat Ali; Yilan Zhang; Mian Zhou; Hongzhi Li; Weiwei Jin; Li Zheng; Xiaochun Yu; Jeremy M Stark; Jeffrey N Weitzel; Binghui Shen
Journal:  Oncogene       Date:  2019-10-15       Impact factor: 9.867

6.  NKX3.1 is regulated by protein kinase CK2 in prostate tumor cells.

Authors:  Xiang Li; Bin Guan; Sam Maghami; Charles J Bieberich
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

7.  RADIOSENSITIVITY TO HIGH ENERGY IRON IONS IS INFLUENCED BY HETEROZYGOSITY for ATM, RAD9 and BRCA1.

Authors:  G Zhou; L B Smilenov; H B Lieberman; T Ludwig; E J Hall
Journal:  Adv Space Res       Date:  2010-09-01       Impact factor: 2.152

8.  Monoallelic but not biallelic loss of Dicer1 promotes tumorigenesis in vivo.

Authors:  I Lambertz; D Nittner; P Mestdagh; G Denecker; J Vandesompele; M A Dyer; J-C Marine
Journal:  Cell Death Differ       Date:  2009-12-18       Impact factor: 15.828

9.  Dicer1 functions as a haploinsufficient tumor suppressor.

Authors:  Madhu S Kumar; Ryan E Pester; Cindy Y Chen; Keara Lane; Christine Chin; Jun Lu; David G Kirsch; Todd R Golub; Tyler Jacks
Journal:  Genes Dev       Date:  2009-11-10       Impact factor: 11.361

Review 10.  Cytogenetic and genetic pathways in therapy-related acute myeloid leukemia.

Authors:  Zhijian Qian; John M Joslin; Thelma R Tennant; Shalini C Reshmi; David J Young; Angela Stoddart; Richard A Larson; Michelle M Le Beau
Journal:  Chem Biol Interact       Date:  2009-12-01       Impact factor: 5.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.